Prof. Marks’ research is focused on clinical aspects of stem cell transplantation, in particular the use of alternative donors, for acute lymphoblastic leukemia (ALL) and infection.

Prof. Marks was the Chief Investigator of a large multinational study investigating the treatment of antifungal prophylaxis following allogenic hematopoietic stem-cell transplantation.